BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17622583)

  • 41. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
    Han G; Chang B; Connor MJ; Sidell N
    Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nerve growth factor activates the RARbeta2 promoter by a Ras-dependent mechanism.
    Cosgaya JM; Aranda A
    J Neurochem; 2001 Feb; 76(3):661-71. PubMed ID: 11158236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA resistance.
    Ren M; Pozzi S; Bistulfi G; Somenzi G; Rossetti S; Sacchi N
    Mol Cell Biol; 2005 Dec; 25(23):10591-603. PubMed ID: 16287870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers.
    Nakayama T; Watanabe M; Yamanaka M; Hirokawa Y; Suzuki H; Ito H; Yatani R; Shiraishi T
    Lab Invest; 2001 Jul; 81(7):1049-57. PubMed ID: 11454993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation.
    Raif A; Marshall GM; Bell JL; Koach J; Tan O; D'andreti C; Thomas W; Sekyere E; Norris M; Haber M; Kavallaris M; Cheung BB
    Cancer Lett; 2009 May; 277(1):82-90. PubMed ID: 19147277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocyte Nuclear Factor 4α (HNF4α) Plays a Controlling Role in Expression of the Retinoic Acid Receptor β (
    Zolfaghari R; Bonzo JA; Gonzalez FJ; Ross AC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downstream codons in the retinoic acid receptor beta -2 and beta -4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription.
    Chen LI; Sommer KM; Swisshelm K
    J Biol Chem; 2002 Sep; 277(38):35411-21. PubMed ID: 12118004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of coactivators and corepressors in the induction of the RARbeta gene in human colon cancer cells.
    Lee MO; Kang HJ
    Biol Pharm Bull; 2002 Oct; 25(10):1298-302. PubMed ID: 12392082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells.
    Bohlken A; Cheung BB; Bell JL; Koach J; Smith S; Sekyere E; Thomas W; Norris M; Haber M; Lovejoy DB; Richardson DR; Marshall GM
    Br J Cancer; 2009 Jan; 100(1):96-105. PubMed ID: 19127267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors.
    Yang H; Zhan Q; Wan YJ
    Hepatology; 2011 Mar; 53(3):865-74. PubMed ID: 21319187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation and antiproliferation effects of retinoic acid receptor beta in hepatoma cells.
    Li C; Wan YJ
    Cancer Lett; 1998 Feb; 124(2):205-11. PubMed ID: 9500212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth inhibition of cervical cancer cells by the human retinoic acid receptor beta gene.
    Geisen C; Denk C; Küpper JH; Schwarz E
    Int J Cancer; 2000 Jan; 85(2):289-95. PubMed ID: 10629091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.
    Almeida VR; Vieira IA; Buendia M; Brunetto AT; Gregianin LJ; Brunetto AL; Klamt F; de Farias CB; Abujamra AL; Lopez PLDC; Roesler R
    Mol Neurobiol; 2017 Dec; 54(10):7610-7619. PubMed ID: 27832522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro.
    Coffey DC; Kutko MC; Glick RD; Swendeman SL; Butler L; Rifkind R; Marks PA; Richon VM; LaQuaglia MP
    Med Pediatr Oncol; 2000 Dec; 35(6):577-81. PubMed ID: 11107121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinoic acid and evernyl-based menadione-triazole hybrid cooperate to induce differentiation of neuroblastoma cells.
    Mendonza JJ; Reddy ST; Dutta H; Makani VKK; Uppuluri VM; Jain N; Bhadra MP
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2651-2665. PubMed ID: 37097334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodeling.
    Youssef EM; Issa JP; Lotan R
    Cancer Biol Ther; 2004 Oct; 3(10):1002-6. PubMed ID: 15467435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoid nutritional status differently affects the expression of Japanese quail retinoic acid receptor-beta isoform transcripts in a tissue-specific manner.
    Fu ZW; Kubo T; Sugahara K; Noguchi T; Kato H
    J Endocrinol; 2001 May; 169(2):281-90. PubMed ID: 11312145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
    Clark RA; Newton M; Qiao J; Lee S; Chung DH
    Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response.
    Halsall JA; Turan N; Wiersma M; Turner BM
    Epigenetics Chromatin; 2015; 8():29. PubMed ID: 26380582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.